Description: This is a concise review of currently approved chemotherapeutic agents and biologic agents used in the treatment of cancer. It is an update of the 2011 edition, and includes four agents approved by the FDA since then.
Purpose: The purpose is to collect the chemotherapeutic and biologic agents currently used in clinical practice in one concise reference. This book also acts as a guide for practicing oncologists to existing chemotherapeutic agents, with information on toxicities and recommendations for dose modifications.
Audience: It rightly targets practicing oncologists, and is also an excellent resource for hematology/oncology fellows and oncology nurses. The contributors are among the leading experts in medical oncology.
Features: The book highlights the key principles of cancer chemotherapy, different chemotherapeutic regimens, and the settings in which they are used. The agents are covered in alphabetical order, with quick reviews of the mechanism of actions, pharmacokinetic, pharmacodynamics, toxicities and special considerations for the agents. There is also a chapter on agents used to manage chemotherapy-induced nausea and vomiting. A shortcoming is the absence of a table/diagram of the different drug classes showing in which group each of the agents belongs.
Assessment: This is an excellent and concise resource for hematologists/oncologists. This edition is justified, especially with the four new agents approved by the FDA in the last year.